
    
      At Screening: Assessments will include CT or MRI of the brain, CT of chest, abdomen and
      pelvis, dermatology assessment, head and neck exam, pelvic and anal exam, ophthalmology exam,
      electrocardiogram (ECG), echocardiogram (ECHO) or multigated acquisition (MUGA) scan, a
      history and physical exam. A core biopsy will be performed within 14 days of study entry.

      During Treatment: The maximum treatment period is 12 months. Patients will be assessed
      monthly while on treatment. Assessments performed will include vital signs assessment and
      physical exam, dermatology exam, ophthalmology exam, echocardiogram (ECHO) or multigated
      acquisition (MUGA) scan, electrocardiogram (ECG), safety blood tests, pelvic and anal exam.

      Follow-up after treatment: Patients will be followed for 5 years. Radiology exams will be
      done to assess for disease. Other assessments performed include vital signs assessment and
      physical exam, dermatology exam, include echogram (ECHO) or multigated acquisition (MUGA)
      scans.
    
  